Aurologistics Llc (aurobindo Pharma Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Aurologistics Llc (aurobindo Pharma Pharmaceutical Import Records from India — 20 Products, $48.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aurologistics Llc (aurobindo Pharma — Pharmaceutical Importer Profile (2026) | 20 Products, $48.3M Trade | TransData Nexus

Import Portfolio — Top 20 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Clopidogrel	Cardiovascular	$6.5M	131	0.8%	14
2	Citalopram	CNS & Psychiatric	$5.3M	106	0.5%	16
3	Spironolactone	Diuretics	$4.0M	80	0.5%	15
4	Ondansetron	Gastrointestinal	$4.0M	87	1.0%	19
5	Rosuvastatin	Cardiovascular	$4.0M	79	0.9%	13
6	Escitalopram	CNS & Psychiatric	$3.9M	78	0.5%	13
7	Iron	Vitamins & Supplements	$3.0M	59	0.6%	10
8	Pioglitazone	Diabetes & Endocrine	$2.9M	105	1.4%	15
9	Clindamycin	Antibiotics	$2.8M	56	3.1%	4
10	Minocycline	Advanced Antibiotics	$2.4M	48	5.3%	4
11	Ciprofloxacin	Antibiotics	$1.9M	39	0.6%	15
12	Atenolol	Cardiovascular	$1.8M	63	2.5%	9
13	Terbinafine	Antifungals	$1.4M	28	2.0%	12
14	Fluoxetine	CNS & Psychiatric	$1.1M	23	0.5%	16
15	Repaglinide	Advanced Diabetes Medications	$972.3K	28	6.7%	4
16	Torsemide	Diuretics	$778.0K	38	1.5%	9
17	Emtricitabine	Antiviral & HIV Medications	$750.0K	15	0.6%	7
18	Clarithromycin	Antibiotics	$550.0K	11	0.6%	9
19	Ribavirin	Antivirals	$112.3K	3	17.4%	2
20	Niacin	Lipid & Metabolism	$83.6K	8	2.2%	8

Aurologistics Llc (aurobindo Pharma imports 20 pharmaceutical products across 13 categories into United States totaling $48.3M.

Aurologistics Llc (aurobindo Pharma — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Aurologistics LLC, a subsidiary of Aurobindo Pharma Limited, is a pharmaceutical importer and distributor based in East Windsor, New Jersey. Established in 2015, the company specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, sourced primarily from India. As a key player in Aurobindo Pharma's U.S. operations, Aurologistics LLC plays a pivotal role in ensuring the efficient delivery of a broad range of generic pharmaceuticals to the U.S. market.

Aurobindo Pharma Limited, headquartered in Hyderabad, India, is a multinational pharmaceutical company known for its extensive portfolio of generic drugs and active pharmaceutical ingredients. The establishment of Aurologistics LLC underscores Aurobindo Pharma's commitment to vertical integration and efficient supply chain management, facilitating the seamless distribution of pharmaceutical products across the United States.

2Distribution Network

Aurologistics LLC operates a state-of-the-art distribution center located at 203 Windsor Center Drive, East Windsor, NJ 08520. This facility spans 59 acres and features a fully automated system equipped with an Automatic Storage and Retrieval System (ASRS) and robotic arms, enhancing the efficiency of inbound and outbound operations. The center's design allows for the handling of a substantial volume of pharmaceutical products, ensuring timely and reliable delivery to various regions within the United States.

The strategic location of the distribution center in East Windsor, New Jersey, positions Aurologistics LLC advantageously to serve the U.S. market. Its proximity to major transportation hubs facilitates efficient logistics and distribution, enabling the company to meet the demands of its diverse customer base across the country.

3Industry Role

In the United States pharmaceutical supply chain, Aurologistics LLC functions as a logistics intermediary, specializing in the importation and distribution of finished pharmaceutical formulations. By sourcing products from Aurobindo Pharma Limited's manufacturing facilities in India, the company ensures a consistent and reliable supply of generic pharmaceuticals to the U.S. market. This role is crucial in bridging the gap between international manufacturing and domestic distribution, facilitating access to a wide range of medications for healthcare providers and patients.

While Aurologistics LLC does not engage in direct manufacturing or retail operations, its strategic position within the supply chain enables it to play a significant role in the availability and distribution of generic pharmaceuticals in the United States. The company's efficient logistics and distribution capabilities contribute to the overall effectiveness of the pharmaceutical supply chain, ensuring that medications reach their intended destinations promptly and in optimal condition.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Aurologistics Llc (aurobindo Pharma

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Aurologistics LLC's sourcing strategy is heavily concentrated on products imported from India, particularly from its parent company, Aurobindo Pharma Limited. This focus is evident in the company's total import value of $48.3 million USD from India, encompassing 1,085 shipments across 20 products in 13 therapeutic categories. The top five imported products—Clopidogrel, Citalopram, Spironolactone, Ondansetron, and Rosuvastatin—collectively account for 49.2% of the total import value, indicating a significant reliance on these specific medications.

This sourcing concentration suggests a strategic choice to leverage Aurobindo Pharma Limited's manufacturing capabilities and established product portfolio. However, the heavy dependence on a single supplier and a limited range of products may pose risks related to supply chain disruptions, regulatory changes, or shifts in market demand. Diversifying the supplier base and product offerings could mitigate these risks and enhance the resilience of Aurologistics LLC's supply chain.

2Supply Chain Resilience

The resilience of Aurologistics LLC's supply chain is closely tied to the stability and reliability of its primary supplier, Aurobindo Pharma Limited. Given the substantial volume of imports from India, any disruptions in Aurobindo Pharma's manufacturing operations—such as production delays, quality control issues, or regulatory challenges—could directly impact Aurologistics LLC's ability to meet U.S. market demands.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth requirements for the safety, efficacy, and quality of drugs imported into the U.S.

Key legislation governing pharmaceutical imports includes the Drug Enforcement Administration (DEA) regulations for controlled substances and the Drug Quality and Security Act (DQSA), which enhances the FDA's authority to oversee the pharmaceutical supply chain. These regulations ensure that imported drugs meet the necessary standards before entering the U.S. market.

The marketing authorization pathway for Indian generics involves obtaining approval from the FDA through the Abbreviated New Drug Application (ANDA) process. This process requires demonstrating that the generic product is bioequivalent to the reference listed drug, ensuring that it performs in the same manner as the innovator drug.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. All foreign drug establishments whose products are imported must register with the FDA and list all their drug products in commercial distribution in the U.S. This registration ensures that the FDA is notified of all regulated products imported into the United States.

Aurologistics Llc (aurobindo Pharma — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Aurologistics LLC's product strategy focuses on importing a diverse range of generic pharmaceutical formulations across 13 therapeutic categories, with significant emphasis on cardiovascular, central nervous system (CNS) and psychiatric, and antibiotic medications

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Aurologistics Llc (aurobindo Pharma

What products does Aurologistics Llc (aurobindo Pharma import from India?

Aurologistics Llc (aurobindo Pharma imports 20 pharmaceutical products across 13 categories. Top imports: Clopidogrel ($6.5M), Citalopram ($5.3M), Spironolactone ($4.0M), Ondansetron ($4.0M), Rosuvastatin ($4.0M).

What is Aurologistics Llc (aurobindo Pharma's total pharmaceutical import value?

Aurologistics Llc (aurobindo Pharma's total pharmaceutical import value from India is $48.3M, based on 1,085 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Aurologistics Llc (aurobindo Pharma focus on?

Aurologistics Llc (aurobindo Pharma imports across 13 categories. The largest: Cardiovascular (25.5%), CNS & Psychiatric (21.4%), Antibiotics (11.0%).

Get Full Aurologistics Llc (aurobindo Pharma Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Aurologistics Llc (aurobindo Pharma

Aurologistics Llc (aurobindo Pharma — Import Portfolio & Supplier Network

What Products Does Aurologistics Llc (aurobindo Pharma Import?

Top Products by Import Value

Aurologistics Llc (aurobindo Pharma Therapeutic Categories — 13 Specializations